Pharma Stability: Insights, Guidelines, and Expertise
Packaging serves as the first line of defense against environmental stressors like oxygen, moisture, light, and microbial ingress. Regulatory agencies such as the USFDA and ICH demand that container closure systems be validated and routinely monitored. Compromised packaging can invalidate stability data and jeopardize regulatory approvals.
Click to read the full article.
The physicochemical properties of the dosage form determine its susceptibility to degradation. Solid tablets may be vulnerable to moisture and oxidation, while liquid formulations require protection from microbial contamination, evaporation, and chemical instability. Hence, packaging material and design must align with the dosage form’s specific vulnerabilities.
Click to read the full article.
ICH Q1A(R2) states that the stability studies should be conducted using the same packaging system as intended for marketing. The packaging must protect the product’s physical, chemical, and microbiological attributes throughout its shelf life. According to Section 2.4 of the guideline, stability testing must evaluate the influence of the packaging on product quality.
Click to read the full article.
Light-sensitive drugs degrade through oxidation, isomerization, or cleavage when exposed to wavelengths between 300–800 nm. Regulatory agencies require evaluation of photostability during development, as outlined in ICH Q1B. Packaging must serve as a protective barrier to minimize this risk.
Click to read the full article.
Packaging must preserve the identity, strength, quality, and purity of the drug under ICH-specified conditions. Evaluations are needed to ensure:
Click to read the full article.
According to ICH Q1A(R2), stability studies must use the same or a representative packaging system intended for marketing. A proper justification is required if an alternate or development packaging is used. The justification:
Click to read the full article.
Multi-layer packaging structures are widely used in pharmaceutical blister packs, sachets, and pouches to provide functional barriers against environmental stressors. These include:
Click to read the full article.
A packaging material is considered “novel” if it:
Click to read the full article.
Risk assessment is not just a regulatory expectation—it’s a critical step to proactively avoid packaging-related stability failures. Proper training ensures teams can:
Click to read the full article.
Common failure modes of packaging materials in stability programs include:
Click to read the full article.
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.